Our findings suggest that S100A4 accelerates tumor progression and promotes chemoresistance through the modulation of proliferation, susceptibility to apoptosis, and epithelial–mesenchymal transition/cancer stem cell properties. This evidence concerns the gene S100A4 and cancer.